Blogs AI-Driven Biomarker Predicts Optimum Length of Treatment for Prostate Cancer Published June 01, 2023 Related News Jung Wook Park News Mention Dr. Jung Wook Park Receives NIH/NCI Grant to Advance New Therapeutic Targets for Aggressive Prostate Cancer July 21, 2026 Duke Pathology News Mention Radioligand Therapy: Using a Targeted Approach to Treat Cancer July 17, 2026 Duke Health Related News Jung Wook Park News Mention Dr. Jung Wook Park Receives NIH/NCI Grant to Advance New Therapeutic Targets for Aggressive Prostate Cancer July 21, 2026 Duke Pathology News Mention Radioligand Therapy: Using a Targeted Approach to Treat Cancer July 17, 2026 Duke Health
Jung Wook Park News Mention Dr. Jung Wook Park Receives NIH/NCI Grant to Advance New Therapeutic Targets for Aggressive Prostate Cancer July 21, 2026 Duke Pathology
News Mention Radioligand Therapy: Using a Targeted Approach to Treat Cancer July 17, 2026 Duke Health
Jung Wook Park News Mention Dr. Jung Wook Park Receives NIH/NCI Grant to Advance New Therapeutic Targets for Aggressive Prostate Cancer July 21, 2026 Duke Pathology
News Mention Radioligand Therapy: Using a Targeted Approach to Treat Cancer July 17, 2026 Duke Health
